Case Report of Erdheim-Chester Disease with Eye Involvement
Author Information
Author(s): Cabuk Kubra Serefoglu, Tellioglu Adem, Karabulut Gamze Ozturk, Nacaroglu Senay Asik, Fazil Korhan, Elverdi Tuğrul, Taskapili Muhittin, Karslioglu Safak
Primary Institution: University of Health Sciences Beyoglu Eye Training and Research Hospital, Istanbul, Turkey
Conclusion
The patient with Erdheim-Chester disease showed improvement with interferon-alpha treatment but experienced vision loss after stopping the therapy.
Supporting Evidence
- The patient presented with bilateral proptosis, chemosis, leg pain, and vision loss.
- Interferon-alpha-2a was started, leading to initial improvement in her condition.
- Vision loss occurred after the patient stopped the interferon treatment.
Takeaway
A woman had a rare disease that affected her eyes and needed special medicine to help her see better, but she stopped taking the medicine and lost some of her vision again.
Methodology
The case was diagnosed based on clinical, radiological, and pathological findings, and treatment was administered with interferon-alpha-2a.
Limitations
The patient discontinued follow-up and treatment, which may have affected the outcomes.
Participant Demographics
A 42-year-old Moldovian female patient.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website